MediWound Dividend

Dividend criteria checks 0/6

MediWound does not have a record of paying a dividend.

Key information

n/a

Dividend yield

n/a

Payout ratio

Industry average yield2.4%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per share-US$0.73
Dividend yield forecast in 3Yn/a

Recent dividend updates

No updates

Recent updates

Revenues Tell The Story For MediWound Ltd. (NASDAQ:MDWD) As Its Stock Soars 25%

May 07
Revenues Tell The Story For MediWound Ltd. (NASDAQ:MDWD) As Its Stock Soars 25%

We're Hopeful That MediWound (NASDAQ:MDWD) Will Use Its Cash Wisely

Feb 28
We're Hopeful That MediWound (NASDAQ:MDWD) Will Use Its Cash Wisely

Optimistic Investors Push MediWound Ltd. (NASDAQ:MDWD) Shares Up 26% But Growth Is Lacking

Feb 01
Optimistic Investors Push MediWound Ltd. (NASDAQ:MDWD) Shares Up 26% But Growth Is Lacking

MediWound Ltd.'s (NASDAQ:MDWD) 26% Share Price Surge Not Quite Adding Up

Dec 18
MediWound Ltd.'s (NASDAQ:MDWD) 26% Share Price Surge Not Quite Adding Up

MediWound Ltd. (NASDAQ:MDWD) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected

Sep 29
MediWound Ltd. (NASDAQ:MDWD) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected

MediWound's NexoBrid for thermal burns in children gets EMA review

Sep 20

Need To Know: Analysts Just Made A Substantial Cut To Their MediWound Ltd. (NASDAQ:MDWD) Estimates

Aug 11
Need To Know: Analysts Just Made A Substantial Cut To Their MediWound Ltd. (NASDAQ:MDWD) Estimates

MediWound GAAP EPS of -$0.13 misses by $0.03, revenue of $4.67M misses by $0.61M

Aug 09

MediWound refiling for NexoBrid to treat severe thermal burns gets FDA review

Aug 03

MediWound adds 13% after favorable data for ulcer candidate

Jul 07

MediWound taps Tzvi Palash as COO

Jun 30

Is MediWound (NASDAQ:MDWD) In A Good Position To Deliver On Growth Plans?

Jun 24
Is MediWound (NASDAQ:MDWD) In A Good Position To Deliver On Growth Plans?

Here's Why We're Watching MediWound's (NASDAQ:MDWD) Cash Burn Situation

Dec 07
Here's Why We're Watching MediWound's (NASDAQ:MDWD) Cash Burn Situation

MediWound: Adjusting My Strategy After NexoBrid CRL

Jul 28

MediWound completes enrollment for interim assessment of mid-stage EscharEx study

Jun 09

MediWound EPS beats by $0.02, beats on revenue

May 05

We're Hopeful That MediWound (NASDAQ:MDWD) Will Use Its Cash Wisely

May 04
We're Hopeful That MediWound (NASDAQ:MDWD) Will Use Its Cash Wisely

MediWound: Managing A Position Ahead Of NexoBrid's PDUFA

May 02

Update: MediWound (NASDAQ:MDWD) Stock Gained 84% In The Last Year

Feb 19
Update: MediWound (NASDAQ:MDWD) Stock Gained 84% In The Last Year

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if MDWD's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if MDWD's dividend payments have been increasing.


Dividend Yield vs Market

MediWound Dividend Yield vs Market
How does MDWD dividend yield compare to the market?
SegmentDividend Yield
Company (MDWD)n/a
Market Bottom 25% (US)1.5%
Market Top 25% (US)4.7%
Industry Average (Pharmaceuticals)2.4%
Analyst forecast in 3 Years (MDWD)n/a

Notable Dividend: Unable to evaluate MDWD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate MDWD's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate MDWD's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as MDWD has not reported any payouts.


Discover strong dividend paying companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.